There was no motor or sensory impairment, ataxia or sphincter incontinence. The clinical situation worsened rapidly, especially the higher cortical functions (severe transcortical sensory aphasia, motor aphasia, complete anterograde amnesia, attention deficit), with appearance of progressive myocloni of the lateral cervical region and in the upper left limb. The blood tests, tumour biomarkers, endocrinological (adrenocorticotropic hormone (ACTH), thyroid stimulating hormone (TSH), cortisol) and immunological (onconeural antibodies) studies, serology (syphilis and HIV) and the brain computerised axial tomography (CAT) scan were all normal. The NMR showed predominantly frontal diffuse cortical atrophy; disturbed cortical signal with bilateral diffusion restriction and parieto-occipital predominance; and signal alterations in the superior cerebellar mesencephalon/peduncle. There was no involvement of the basal ganglia. The EEG showed diffuse periodic short-interval diffuse discharges (PSIDDs), and the analysis of the cerebrospinal fluid was positive for the 14-3-3 protein. The brain SPECT showed diffuse cortical hypoperfusion, which was more severe in the left frontotemporal and bilateral parietal regions. The patient's condition worsened gradually over the next 5-6 weeks, when akinetic mutism and dysphagia to both solids and liquids appeared. The patient died from respiratory sepsis at three months. The cerebropathological diagnosis confirmed the type CJD spongiform encephalopathy.
Discussion
CJD is a rare cause of dementia (incidence 1:1,000,000). It generally appears in the fifth or sixth decade of life, with no distinction between sexes. Among the associated risk factors, reports have described cases related to the administration of growth hormone and gonadotropin, the performance of cornea and liver transplants, and the use of contaminated materials in neurosurgery [1] . Several subtypes of CJD have been described: 85%-90% are sporadic, 5%-15% are hereditary and 1% is acquired. The typical clinical presentation is a rapidly progressive dementia with behavioural changes (particularly in younger patients), cortical impairments (aphasia, amnesia and attention deficit), myocloni, corticospinal tract alterations, and akinetic mutism (usually occurring in the final stages) [2] . At times, CJD can present as a progressive pseudodementia, secondary to a depressive syndrome, or rarely, as a systemic disorder (case 1) [3, 4] .
It is important to consider this disease within a differential diagnosis of rapidly progressive dementia. The brain NMR and EEG may suggest the probability of CJD. Similar findings in the NMR and EEG also appear in metabolic and toxic encephalopathies, viral encephalomyelitis (HIV and herpes virus) and paraneoplastic syndromes [5] . The positive identification of 14-3-3 protein in cerebrospinal fluid (sensitivity 92%, specificity 80%) is one of the most frequently used analytical methods for the diagnosis [6] . Mean survival usually ranges from six months to a year [7] . Definitive diagnosis is confirmed by pathological anatomy, but criteria for clinical suspicion have been described (presence of progressive dementia + two typical clinical symptoms (myoclonus, extrapyramidalism, cerebellar degeneration, akinetic mutism) + abnormal EEG or 14-3-3 protein in cerebrospinal fluid or suggestive findings on NMR (diffusion weighted imaging, DWI, or fluid-attenuated inversion recovery, FLAIR) [8, 9] .
The anatomopathological diagnosis by standardised autopsy should be mandatory in all cases where suspicion exists, with a particular importance given to identifying hereditary cases and other genetic prion disease (fatal familial insomnia and GerstmannStraussler-Scheinker disease). Currently, there is no treatment for this disease, and the vital prognosis is ominous in the short term.
We want to highlight the need to consider this pathology, not only in the study of a patient with cognitive decline, but also in systemic syndromes associated with neuropsychiatric disorders. The diagnosis of suspicion should be made as soon as possible, as epidemiological and preventive measures must be foremost from the very beginning.
Conclusion
CJD is very rare form of rapidly progressive dementia that should be considered once the most frequent processes (Alzheimer's, Parkinson's, frontotemporal dementia, alcoholic dementia and Lewy body dementia) have been ruled out. Up to 90% of cases are sporadic, although clusters in incidence have been described (probably due to greater epidemiological vigilance). The diagnosis of suspicion is essential, keeping in mind the possibility of atypical presentation as a systemic syndrome.
